A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis

Calcific aortic valve stenosis (CAVS) is a common and life-threatening heart disease and the current treatment options cannot stop or delay its progression. A GWAS on 1009 cases and 1017 ethnically matched controls was combined with a large-scale eQTL mapping study of human aortic valve tissues (n = 233) to identify susceptibility genes for CAVS. Replication was performed in the UK Biobank, including 1391 cases and 352,195 controls. A transcriptome-wide association study (TWAS) reveals PALMD (palmdelphin) as significantly associated with CAVS. The CAVS risk alleles and increasing disease severity are both associated with decreased mRNA expression levels of PALMD in valve tissues. The top variant identified shows a similar effect and strong association with CAVS (P = 1.53 × 10−10) in UK Biobank. The identification of PALMD as a susceptibility gene for CAVS provides insights into the genetic nature of this disease, opens avenues to investigate its etiology and to develop much-needed therapeutic options.Progressive remodeling and calcification of the aortic valve leads to calcific aortic valve stenosis (CAVS) and, ultimately, heart failure. In a combined GWAS and TWAS approach, Thériault et al. identify PALMD as a candidate causal gene for CAVS, which is further supported by Mendelian randomization.

[1]  Y. Bossé,et al.  Calcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease , 2015, Circulation. Cardiovascular genetics.

[2]  B. Horne,et al.  Evidence for a Heritable Component in Death Resulting From Aortic and Mitral Valve Diseases , 2004, Circulation.

[3]  J. Blanc,et al.  Heterogeneous geographic distribution of patients with aortic valve stenosis: arguments for new aetiological hypothesis , 2005, Heart.

[4]  Alkes L. Price,et al.  Integrative approaches for large-scale transcriptome-wide association studies , 2015 .

[5]  Nilanjan Chatterjee,et al.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.

[6]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[7]  Nicholas J. Schork,et al.  Preprocessing and Quality Control Strategies for Illumina DASL Assay-Based Brain Gene Expression Studies with Semi-Degraded Samples , 2012, Front. Gene..

[8]  Xumeng Zhang,et al.  Palmdelphin promotes myoblast differentiation and muscle regeneration , 2017, Scientific Reports.

[9]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[10]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[11]  M. Kirby,et al.  Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. , 2005, Developmental biology.

[12]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[13]  N. Copeland,et al.  The paralemmin protein family: identification of paralemmin-2, an isoform differentially spliced to AKAP2/AKAP-KL, and of palmdelphin, a more distant cytosolic relative. , 2001, Biochemical and biophysical research communications.

[14]  Jon White,et al.  Selecting instruments for Mendelian randomization in the wake of genome-wide association studies , 2016, International journal of epidemiology.

[15]  V. Probst,et al.  Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.

[16]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[17]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[18]  Y. Bossé,et al.  Replication of genetic association studies in aortic stenosis in adults. , 2011, The American journal of cardiology.

[19]  W. Paulus,et al.  Aortic stenosis , 2009, The Lancet.

[20]  N. Taira,et al.  Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage , 2014, Cell Death and Disease.

[21]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[22]  R. Goeree,et al.  Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update. , 2013, Ontario health technology assessment series.

[23]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[24]  Y. Bossé,et al.  Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves , 2009, Circulation. Cardiovascular genetics.

[25]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[26]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[27]  E. Petrasch‐Parwez,et al.  Molecular characterization and immunohistochemical localization of palmdelphin, a cytosolic isoform of the paralemmin protein family implicated in membrane dynamics. , 2005, European journal of cell biology.

[28]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[29]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[30]  Alan M. Kwong,et al.  A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.

[31]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[32]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[33]  B. Warren,et al.  Calcification of the aortic valve: Its progression and grading , 1997, Pathology.

[34]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[35]  Y. Bossé,et al.  Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. , 2008, Journal of the American College of Cardiology.

[36]  S. Body,et al.  Embryonic Development of the Bicuspid Aortic Valve , 2015, Journal of cardiovascular development and disease.

[37]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[38]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[39]  A. Kraja,et al.  Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships: The Hypertension Genetic Epidemiology Network Study , 2007, Hypertension.

[40]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[41]  Jie Huang,et al.  Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function , 2017, The Journal of clinical investigation.

[42]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[43]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[44]  Y. Bossé,et al.  NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis. , 2013, The Journal of heart valve disease.

[45]  F. Harrell,et al.  Racial Differences in the Prevalence of Severe Aortic Stenosis , 2014, Journal of the American Heart Association.

[46]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[47]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[48]  X. Estivill,et al.  PALML, a novel paralemmin-related gene mapping on human chromosome 1p21. , 2001, Gene.

[49]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[50]  Y. Bossé,et al.  RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing. , 2016, Physiological genomics.

[51]  K. O’Brien.  Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[52]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[53]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[54]  R. Sacco,et al.  Ethnic differences in aortic valve thickness and related clinical factors. , 2010, American heart journal.